MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans

SARS-CoV-2 antibodies develop within two weeks of infection, but wane relatively rapidly post-infection, raising concerns about whether antibody responses will provide protection upon re-exposure. Here we revisit T-B cooperation as a prerequisite for effective and durable neutralizing antibody respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Andrea, Ozturk, Kivilcim, Zanetti, Maurizio, Carter, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781323/
https://www.ncbi.nlm.nih.gov/pubmed/33398284
http://dx.doi.org/10.1101/2020.12.26.424449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781323/
https://www.ncbi.nlm.nih.gov/pubmed/33398284
http://dx.doi.org/10.1101/2020.12.26.424449

Ejemplares similares